vimarsana.com

மொழிபெயர்ப்பு ஆரோக்கியம் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Novel nanotech improves cystic fibrosis antibiotic by 100,000-fold

 E-Mail IMAGE: After four hours, if the infection is not treated it kills all the cells (line 1); Unformulated tobramycin keeps the cells alive, but it does not eradicate the infection (line. view more  Credit: UniSA World-first nanotechnology developed by the University of South Australia could change the lives of thousands of people living with cystic fibrosis (CF) as groundbreaking research shows it can improve the effectiveness of the CF antibiotic Tobramycin, increasing its efficacy by up to 100,000-fold. The new technology uses a biomimetic nanostructured material to augment Tobramycin - the antibiotic prescribed to treat chronic Pseudomonas aeruginosa lung infections in severe cases of CF - eradicating the infection in as little as two doses.

New Study Seeks To Improve Covid Testing Access To Natives, Latinx

SPR s Doug Nadvornick reports. Researchers from two Northwest universities are wondering about the most effective way to get Covid testing supplies to Native American and Latino people. They’ve received a grant from the National Institutes of Health to test their ideas in Washington and Montana. Alexandra Adams from Montana State University is the principal investigator of the project known as Protecting Our Communities. “What we know is that the Covid-19 pandemic has disproportionately affected people who identify as American Indian or Hispanic/Latino, she said. Part of that is because people in those communities often struggle to access health care. So Adams and her research colleagues at the University of Washington School of Medicine picked out a strategy.

Study exposes muscle mania stronghold on Australian young people

Date Time Study exposes muscle mania stronghold on Australian young people A world-first study has revealed that Muscle Dysmorphia (MD) is more common in Australian young people than other obsessive compulsive and eating disorders. Researchers from Western Sydney University analysed data from the 2017 EveryBODY study – a population-based survey of eating and body image disorders – to investigate and report on the prevalence of MD. The results, published in Psychological Medicine, reveal that – of the 3,618 Australian adolescents surveyed – 1.8% met the criteria for MD. Dr Deborah Mitchison, from the University’s Translational Health Research Institute (THRI) and School of Medicine, said a prevalence of 1.8% is significant and highly concerning.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.